Olema Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US68062P1066

SecurityOLMA / Olema Pharmaceuticals, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership133,125 shares
Latest Disclosed Value $ 3,328,125
Barclays Plc reports 27.24% increase in ownership of OLMA / Olema Pharmaceuticals, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 133,125 shares of Olema Pharmaceuticals, Inc. (US:OLMA) valued at $3,328,125 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 104,624 shares of Olema Pharmaceuticals, Inc.. This represents a change in shares of 27.24% during the quarter. The current value of the position is $1,421,775 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F OLEMA PHARMACEUTICALS COM 68062P106 133,125 28,501 27.24 3,328 225.00 0.0008
2026-03-31 2025-09-30 13F/A-3 OLEMA PHARMACEUTICALS COM 68062P106 104,624 -51,216 -32.86 1,024 54.45 0.0002
2026-03-19 2025-09-30 13F/A-2 OLEMA PHARMACEUTICALS COM 68062P106 94,915 -60,925 1,133 0.0003
2025-11-12 2025-09-30 13F OLEMA PHARMACEUTICALS COM 68062P106 104,624 -51,216 1,024 0.0002
2026-02-27 2025-06-30 13F/A-2 OLEMA PHARMACEUTICALS COM 68062P106 155,840 2,736 1.79 664 15.30 0.0002
2025-08-14 2025-06-30 13F/A-1 OLEMA PHARMACEUTICALS COM 68062P106 155,840 2,736 1 0.0002
2025-08-13 2025-06-30 13F OLEMA PHARMACEUTICALS COM 68062P106 155,840 2,736 1 0.0000
2026-03-17 2025-03-31 13F/A-1 OLEMA PHARMACEUTICALS COM 68062P106 153,104 38,225 33.27 576 -14.05 0.0002
2025-05-15 2025-03-31 13F OLEMA PHARMACEUTICALS COM 68062P106 153,104 38,225 1 0.0002
2026-03-19 2024-12-31 13F/A-1 OLEMA PHARMACEUTICALS COM 68062P106 114,879 19,964 21.03 670 -40.95 0.0002
2025-02-13 2024-12-31 13F OLEMA PHARMACEUTICALS COM 68062P106 114,879 19,964 1 0.0002
2026-03-31 2024-09-30 13F/A-2 OLEMA PHARMACEUTICALS COM 68062P106 94,915 48,614 105.00 1,133 126.60 0.0003
2024-11-19 2024-09-30 13F/A-1 OLEMA PHARMACEUTICALS COM 68062P106 94,915 48,614 1 0.0003
2024-11-15 2024-09-30 13F OLEMA PHARMACEUTICALS COM 68062P106 94,915 48,614 1 0.0001
2026-03-23 2024-06-30 13F/A-1 OLEMA PHARMACEUTICALS COM 68062P106 46,301 3,491 8.15 501 3.31 0.0002
2024-08-14 2024-06-30 13F OLEMA PHARMACEUTICALS COM 68062P106 46,301 3,491 1 0.0002
2026-03-24 2024-03-31 13F/A-1 OLEMA PHARMACEUTICALS COM 68062P106 42,810 -586 -1.35 485 -20.39 0.0002
2024-05-15 2024-03-31 13F OLEMA PHARMACEUTICALS COM 68062P106 42,810 -586 0 0.0002
2026-03-25 2023-12-31 13F/A-1 OLEMA PHARMACEUTICALS COM 68062P106 43,396 38,739 831.84 609 966.67 0.0002
2024-02-15 2023-12-31 13F OLEMA PHARMACEUTICALS COM 68062P106 43,396 38,739 1 0.0002
2026-03-26 2023-09-30 13F/A-1 OLEMA PHARMACEUTICALS COM 68062P106 4,657 -695 -12.99 58 18.75 0.0000
2023-11-07 2023-09-30 13F OLEMA PHARMACEUTICALS COM 68062P106 4,657 -695 0 0.0000
2026-03-30 2023-06-30 13F/A-2 OLEMA PHARMACEUTICALS COM 68062P106 5,352 730 15.79 48 200.00 0.0000
2023-09-20 2023-06-30 13F/A-1 OLEMA PHARMACEUTICALS COM 68062P106 5,352 730 0 0.0000
2023-08-03 2023-06-30 13F OLEMA PHARMACEUTICALS COM 68062P106 5,352 730 0 0.0000
2026-03-30 2023-03-31 13F/A-1 OLEMA PHARMACEUTICALS COM 68062P106 4,622 714 18.27 16 77.78 0.0000
2023-05-04 2023-03-31 13F OLEMA PHARMACEUTICALS COM 68062P106 4,622 714 0 0.0000
2026-03-30 2022-12-31 13F/A-1 OLEMA PHARMACEUTICALS COM 68062P106 3,908 -1,669 -29.93 10 -43.75 0.0000
2023-02-13 2022-12-31 13F OLEMA PHARMACEUTICALS COM 68062P106 3,908 -1,669 0 0.0000
2022-11-03 2022-09-30 13F OLEMA PHARMACEUTICALS COM 68062P106 5,577 1,749 45.69 16 0.00 0.0000
2022-08-12 2022-06-30 13F OLEMA PHARMACEUTICALS COM 68062P106 3,828 -4,212 -52.39 16 -52.94 0.0000
2022-05-16 2022-03-31 13F OLEMA PHARMACEUTICALS COM 68062P106 8,040 8,040 34 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.